Art

J-GLOBAL ID：201702277425238626   Reference number：17A0268428

Pharmacotherapies for renal cell carcinoma in Japan

日本における腎細胞癌に対する薬物療法

Author (2)： Yoshimura Kazuhiro (Department of Urology, Kinki University Faculty of Medicine, Osaka-sayama, Osaka, Japan) ,  Uemura Hirotsugu (Department of Urology, Kinki University Faculty of Medicine, Osaka-sayama, Osaka, Japan)
Material： International Journal of Urology (Web)  (Int J Urol (Web))
Volume： 23  Issue： 3  Page： 194-202  Publication year： 2016 
JST Material Number： U0707A  ISSN： 1442-2042  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *renal cell carcinoma ,...
Semi thesaurus term： cytokine therapy

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0268428&from=J-GLOBAL&jstjournalNo=U0707A") }}

Author keywords (3)： Japan ,  pharmacotherapy ,  renal cell carcinoma

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Urogenital tumors(=neoplasms)  (GM04000S) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (2)： Sorafenib ,  Sirolimus

Reference (24)：

• Wada Y, Takahashi W, Kawano Y, Eto M. Current status of pharmacotherapy against metastatic renal cell carcinoma in Japan. Int. J. Urol. 2012; 19: 284-95.
• Rini BI. Campbell SC and Escudier B. Renal cell carcinoma. Lancet 2009; 373: 1119-32.
• Biswas S, Eisen T. Immunotherapeutic strategies in kidney cancer - when TKIs are not enough. Nat. Rev. Clin. Oncol. 2009; 6: 478-87.
• Coppin C, Porzsolt F, Kumpf J, Coldman A, Wilt T. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst. Rev. 2000; 3: CD001425.
• Aso Y. A phase II trial of S-6820 (recombinant interleukin-2) on renal cell carcinoma refractory to interferon. Hinyokigeka 1995; 8: 75-86. (In Japanese.)

Terms in the title (3)： 日本 ,  腎細胞癌 ,  薬物療法